Macrophages in the microenvironment of head and neck cancer: potential targets for cancer therapy.

作者: Diane Evrard , Petr Szturz , Annemilaï Tijeras-Raballand , Lucile Astorgues-Xerri , Chloé Abitbol

DOI: 10.1016/J.ORALONCOLOGY.2018.10.040

关键词: Targeted therapyTumor microenvironmentCancer researchMacrophage colony-stimulating factorImmune systemPhenotypeHead and neck cancerPoor prognosisCancer therapyMedicine

摘要: … , mifamurtide, is incorporated as an integral component of the liposomal bilayer. Mifamurtide is … The encapsulation of mifamurtide into liposomes has been shown in vitro to enhance the …

参考文章(114)
E Teske, G R Rutteman, W Misdorp, R van Noort, T S vd Ingh, Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine (L-MTP-PE): a randomized clinical trial in dogs with mammary carcinoma. Anticancer Research. ,vol. 18, pp. 1015- 1019 ,(1998)
William D. Tap, Zev A. Wainberg, Stephen P. Anthony, Prabha N. Ibrahim, Chao Zhang, John H. Healey, Bartosz Chmielowski, Arthur P. Staddon, Allen Lee Cohn, Geoffrey I. Shapiro, Vicki L. Keedy, Arun S. Singh, Igor Puzanov, Eunice L. Kwak, Andrew J. Wagner, Daniel D. Von Hoff, Glen J. Weiss, Ramesh K. Ramanathan, Jiazhong Zhang, Gaston Habets, Ying Zhang, Elizabeth A. Burton, Gary Visor, Laura Sanftner, Paul Severson, Hoa Nguyen, Marie J. Kim, Adhirai Marimuthu, Garson Tsang, Rafe Shellooe, Carolyn Gee, Brian L. West, Peter Hirth, Keith Nolop, Matt van de Rijn, Henry H. Hsu, Charles Peterfy, Paul S. Lin, Sandra Tong-Starksen, Gideon Bollag, Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor. The New England Journal of Medicine. ,vol. 373, pp. 428- 437 ,(2015) , 10.1056/NEJMOA1411366
R H Wiltrout, R B Herberman, M Schneider, J E Talmadge, M Collins, H Phillips, Augmentation of NK cell activity in tissue specific sites by liposomes incorporating MTP-PE Journal of Immunology. ,vol. 135, pp. 1477- 1483 ,(1985)
Ivan Shabo, Olle Stål, Hans Olsson, Siv Doré, Joar Svanvik, Breast cancer expression of CD163, a macrophage scavenger receptor, is related to early distant recurrence and reduced patient survival. International Journal of Cancer. ,vol. 123, pp. 780- 786 ,(2008) , 10.1002/IJC.23527
S Sone, M Ogawara, S Mutsuura, E Tsubura, Potentiating effect of muramyl dipeptide and its lipophilic analog encapsulated in liposomes on tumor cell killing by human monocytes. Journal of Immunology. ,vol. 132, pp. 2105- 2110 ,(1984)
Nobuyuki Fujii, Kohei Shomori, Tatsushi Shiomi, Motoki Nakabayashi, Chikako Takeda, Kazuo Ryoke, Hisao Ito, Cancer‐associated fibroblasts and CD163‐positive macrophages in oral squamous cell carcinoma: their clinicopathological and prognostic significance Journal of Oral Pathology & Medicine. ,vol. 41, pp. 444- 451 ,(2012) , 10.1111/J.1600-0714.2012.01127.X
Takenori Uehara, Tomohiro Fujiwara, Ken Takeda, Toshiyuki Kunisada, Toshifumi Ozaki, Heiichiro Udono, Immunotherapy for Bone and Soft Tissue Sarcomas BioMed Research International. ,vol. 2015, pp. 820813- 820813 ,(2015) , 10.1155/2015/820813
Baruj Benacerraf, Ronald N. Germain, Louis Chedid, Masanobu Sugimoto, Enhancement of Carrier-Specific Helper T Cell Function by the Synthetic Adjuvant, N-Acetyl Muramyl-l-Alanyl-d-Isoglutamine (MDP) Journal of Immunology. ,vol. 120, pp. 980- 982 ,(1978)
Nicholas Butowski, Howard Colman, John F. De Groot, Antonio M. Omuro, Lakshmi Nayak, Patrick Y. Wen, Timothy F. Cloughesy, Adhirai Marimuthu, Sam Haidar, Arie Perry, Jason Huse, Joanna Phillips, Brian L. West, Keith B. Nolop, Henry H. Hsu, Keith L. Ligon, Annette M. Molinaro, Michael Prados, Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study Neuro-oncology. ,vol. 18, pp. 557- 564 ,(2016) , 10.1093/NEUONC/NOV245